Search filters

List of works by Josée M. Zijlstra

18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma

scientific article published on 15 January 2015

18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.

scientific article

18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma

scientific article published in November 2003

18F‐fluoro‐deoxyglucose positron emission tomography in assessment of myeloma‐related bone disease: A systematic review ⬇️

scientific article published on April 15, 2012

18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair

scientific article published on 8 January 2014

89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo

scientific article published on 30 May 2019

90yttrium Ibritumomab Tiuxetan-BEAM Followed by Autologous Stem Cell Transplantation Significantly Improves Overall Survival After Rituximab Containing Induction Therapy in Patients with High-Risk Aggressive B Cell Non-Hodgkin's Lymphoma ⬇️

scholarly article

A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

scholarly article

A randomised controlled trial assessing the effect of oral diazepam on 18F-FDG uptake in the neck and upper chest region

scientific article published on 27 March 2009

Abscopal Effect of Radiotherapy and Nivolumab in Relapsed or Refractory Hodgkin Lymphoma (AERN): An International Multicenter Single-Arm Two-Stage Phase II GHSG Trial ⬇️

scholarly article

Active patient participation in the development of an online intervention

scientific article

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

scientific article published on 07 May 2020

An Integrated Process and Outcome Evaluation of a Web-Based Communication Tool for Patients With Malignant Lymphoma: Randomized Controlled Trial

scientific article published on 29 July 2016

Assessment of Residual Bulky Tumor Using FDG-PET In Patients with Advanced-Stage Hodgkin Lymphoma After Completion of Chemotherapy: Final Report of the GHSG HD15 Trial ⬇️

scholarly article

Automated segmentation of baseline metabolic total tumor burden in diffuse large B-cell lymphoma: which method is most successful ?

scientific article published on 17 July 2020

Barriers and facilitators to effective communication experienced by patients with malignant lymphoma at all stages after diagnosis

scientific article published on 29 July 2013

Baseline PET as prognostic marker for Hodgkin?

scientific article

Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET ⬇️

scientific article published on January 5, 2012

Bortezomib Maintenance Therapy after Induction with R-CHOP, ARA-C and Autologous Stem Cell Transplantation in Newly Diagnosed MCL Patients, Results of a Multicenter Phase II HOVON Study ⬇️

scholarly article

Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial

scientific article published on 09 March 2020

Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure

scientific article published on 18 July 2017

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes

scientific article published on 10 August 2009

Combining Brentuximab Vedotin with DHAP as Salvage Treatment in Relapsed/Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE study ⬇️

scholarly article

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

scientific article published on 09 April 2020

Communication during haematological consultations; patients' preferences and professionals' performances.

scientific article

Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review

scientific article published on 25 April 2013

Computed Tomography Observer Agreement in Staging Malignant Lymphoma

scientific article published on 23 November 2015

Does 18F-Fluorodeoxyglucose Outperform 18F-Fluorothymidine When Using Positron Emission Tomography in Predicting Transformation of Indolent Non-Hodgkin's Lymphoma, ⬇️

scholarly article

Does PET Reconstruction Method Affect Deauville Scoring in Lymphoma Patients?

scientific article published on 06 April 2018

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

scientific article (publication date: 20 March 2012)

Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma

scientific article published on 26 September 2006

Effect of Prior Therapy on the Efficacy and Safety of Oral Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Study ⬇️

scholarly article

Efficacy and cost-utility of the eHealth application 'Oncokompas', supporting patients with incurable cancer in finding optimal palliative care, tailored to their quality of life and personal preferences: a study protocol of a randomized controlled

scientific article published on 23 October 2019

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial

scientific article published on 5 April 2010

Erratum to: Methods for evaluating medical tests and biomarkers

scientific article published on 30 March 2017

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

scientific article published on January 2010

FDG PET in lymphoma: the need for standardization of interpretation. An observer variation study

scientific article published in October 2007

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

scientific article

FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?

scientific article published on November 2016

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy ⬇️

scholarly article

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant, ⬇️

scholarly article

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

scientific article

Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015

scientific article published on 06 February 2020

Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with 90Yttrium ibritumomab tiuxetan‐BEAM and autologous stem cell transplantation ⬇️

scientific article published on 09 January 2012

Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.

scientific article published on 20 June 2017

Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments

scientific article published in November 2009

Interobserver agreement of interim and end-of-treatment 18F-FDG PET/CT in diffuse large B-cell lymphoma (DLBCL): impact on clinical practice and trials.

scientific article

Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis

scientific article published on 17 June 2019

Long-term cause-specific mortality in hodgkin lymphoma patients

scientific article published on 22 December 2020

Malignant mesothelioma after radiation treatment for Hodgkin lymphoma

scientific article published on 20 February 2009

Methods for Evaluating Medical Tests and Biomarkers

article by Gowri Gopalakrishna et al published February 2017 in Diagnostic and Prognostic Research

No Harmful Impact of 90Yttrium-Ibritumomab Tiuxetan Combined with BEAM On Bone Marrow Microenvironment. ⬇️

scholarly article

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial

scientific article published on 22 December 2014

Optimizing Workflows for Fast and Reliable Metabolic Tumor Volume Measurements in Diffuse Large B Cell Lymphoma

scientific article published on 28 January 2020

Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma

scientific article published on 30 August 2018

Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer

scientific article published on 27 December 2018

PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability

scientific article published on 30 March 2020

PET-CT: reliable cornerstone for Hodgkin lymphoma treatment?

scientific article published in March 2016

PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group ⬇️

scholarly article

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

scientific article published on 20 October 2017

Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma

scientific article

Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study

scientific article published on 31 October 2018

Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients.

scientific article

Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group

scientific article published on 10 September 2019

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

scientific article published on 29 August 2008

Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis

scientific article published on 23 August 2018

Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography

scientific article published on 11 July 2006

Primary therapy and relative survival in classical Hodgkin lymphoma: a nationwide population-based study in the Netherlands, 1989-2017

scientific article published on 28 May 2020

Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016

scientific article published on 04 November 2019

Quantitative implications of the updated EARL 2019 PET-CT performance standards

scientific article published on 26 December 2019

Radiation therapy in early stage Hodgkin's disease: long-term results and adverse effects

scientific article

Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease

scientific article published on January 2006

Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA)

Reduced Intensity of Chemotherapy and PET-Guided Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma: The GHSG HD15 Final Results ⬇️

scholarly article

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study Group

scientific article published on 20 December 2017

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

scientific article

Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma

scientific article

Risk of multiple primary malignancies following treatment of Hodgkin lymphoma

scientific article published on 16 April 2014

Rituximab (Mabthera) Improves the Treatment Results of DHAP-VIM-DHAP and ASCT in Relapsed/Progressive Aggressive CD20+ NHL. A Prospective Randomized HOVON Trial. ⬇️

scholarly article

Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial

scientific article published on 30 October 2007

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

scientific article published on 07 January 2019

Rituximab-PECC Induction Followed by 90y-Ibritumomab Tiuxetan Consolidation in Relapsed or Refractory DLBCL Patients Who Are Not Eligible for or After ASCT: Preliminary Results From a Phase II HOVON Study. ⬇️

scholarly article

Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study

scientific article published on 10 July 2019

Rituximab-Pecc Induction Followed By 90y-Ibritumomab Tiuxetan Consolidation in Relapsed or Refractory DLBCL Patients Who Are Not Eligible for or Have Failed ASCT: Results from a Phase II HOVON Study ⬇️

scholarly article

Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial

scientific article published on 11 December 2019

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.

scientific article published on December 2015

Self-Reported Sexual Function in Sexually Active Male Hodgkin Lymphoma Survivors

scientific article published on 02 June 2020

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

scientific article published on 01 July 2020

Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma

scientific article published on 15 May 2019

Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non-GCB Subtypes: The Phase 2b Sadal Study ⬇️

scholarly article

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials

scientific article published on 15 August 2008

The eHealth self-management application 'Oncokompas' that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?

scientific article published on 21 December 2020

Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial

scientific article published on 05 December 2019

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial

scientific article published on 19 December 2019

Updating PET/CT performance standards and PET/CT interpretation criteria should go hand in hand

scientific article published on 29 October 2019

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

scientific article published on 22 January 2007

Paulina is supported by:

About Paulina

Help